Director/PDMR Shareholding

RNS Number : 8751Q
Oxford Biomedica PLC
15 September 2017
 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

 

1

Issuer

Oxford BioMedica PLC

2

Reason for notification

Notification relates to DTR 3.1.2R

3

Name of PDMR

Martin Diggle

4

Connected person

Notification relates to following connected persons:

Vulpes Testudo Fund

5

Notification in respect of

Notification in respect of holdings of persons in 4 above

6

Description of shares

Oxford BioMedica PLC ordinary shares of 1p each

7

Name of registered shareholders and number of shares

Vulpes Life Sciences Fund - 549,932,000 shares

Vulpes Testudo Fund - 30,976,434 shares

 

8

Nature of transaction

Acquisition

9

Number of shares acquired

 

Vulpes Testudo Fund - 100,000 shares

 

 

10

Percentage of issued class acquired

Vulpes Testudo Fund- 0.003%

 

11

Shares disposed

N/A

 

12

Percentage of issued class disposed

N/A

 

13/14

Price per share of transactions, and date

Vulpes Testudo Fund

Bought 100,000 shares @ £0.081,   14 Sep 2017

 

15

Total holding following notification and total percentage holding following notification

Vulpes Life Sciences Fund - 549,932,000 shares

17.7%

Vulpes Testudo Fund - 31,076,434 shares

1.0%

16

Date issuer informed

15 Sep 2017




23

Any additional information

None

24

Contact name and telephone number

S. Paynter, Chief Financial Officer

Oxford BioMedica

+44 (0)1865 783000

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGIGDCCBBBGRU
UK 100

Latest directors dealings